SUMMARY Five adults with acute extraocular muscle palsies followed by limited recovery of muscle function were treated with injections of botulinum toxin A to the ipsilateral antagonist of the affected muscle. Three were cases of unilateral sixth nerve palsy, one of bilateral sixth nerve palsy, and one of third nerve palsy. After a period of paralysis, during which the strabismus was overcorrected, the injected muscle recovered and binocular sensory and motor functions were restored and have been maintained for periods of up to 21 months. The treatment is a safe and effective alternative to surgery, particularly in cases in which a general anaesthetic is not advisable.
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Adult neurogenic ocular palsies present problems of both diagnosis and management. Despite full neurological investigation the underlying cause may not be established,'2 and, even if specific treatment can be instituted, recovery of function may not be complete. Binocularity may not be restored even with a compensatory head posture, or prisms, and despite alternate patching suppression frequently develops. Orthoptic assessment included measurement of the angle of strabismus at near and distance fixation, and the extent of the extraocular movements ( 2). The saccadic velocity in the direction of the palsied muscle was judged clinically to be either normal or slow. Fusion and stereopsis were investigated on the synoptophore. BTXA, 3*12x Ig, was injected under electromyographic control as previously described'2 into the muscle indicated in Table 3 . Clinical assessment and orthoptic measurements were repeated at one, two, and four weeks after treatment, and the injections repeated at the same dosage if necessary to produce an overcorrection of the original strabismus (Table  IV) . In case 2 pilocarpine drops 0-1% were applied twice a day to the left eye to mediate accommodation in an attempt to re-establish fusion.8 Follow-up thereafter has been from 4 to 21 months.
Results
There were no local or systemic side effects of the treatment.
The ocular deviation was overcorrected in all cases for a period of between three and five weeks (Table  3) , when single vision could be obtained in only one position of gaze. As the treated muscle recovered function, however, the area of binocular single vision (BSV) gradually enlarged. Fig. 1A shows the Hess chart in case 2 before treatment. After the left lateral rectus had been treated, the horizontal muscles on the right eye overacted in both adduction and abduction, but there was a small central area of single temp. (Fig. 1B) . The area enlarged as the lateral rectus recovered function (Fig. 1C) . Fig. 2A shows the Hess chart in case 3 before treatment. In Fig. 2B , after the left medial rectus had been treated, single vision could be obtained in left gaze, but the patient showed an increasing exotropia as he moved into right gaze. In Fig. 2C require surgery on both eyes for the third and bilateral sixth nerve palsies and, in two of the three cases of unilateral abduction deficit, operation under local anaesthesia. While the benefit of surgery, provided the suppression of the deviating eye was overcome, would be immediate, the potential area of binocular single vision, already limited in cases 2, 3, and 5, would be further compromised by operative reduction of ocular rotations in cases 2 and 3. The patients would be in hospital for three days and need to have local anti-inflammatory treatment for one to two weeks.
In contrast, BTXA treatment of strabismus is an outpatient procedure under local anaesthetic, and, if the muscle to be injected has not been previously operated on, the treatment is easy and painless. There are no systemic side effects," 12 and, while there is a theoretical danger of ocular perforation, this has not occurred in over 400 injections by the authors. The eye is padded for two hours, JS Elston andJ P Lee and thereafter no local treatment is needed.
The period of reversal of the diplopia and horizontal incomitance associated with the newly paralysed muscle was disturbing for all the patients treated. Although there was one position of gaze in which single vision could be obtained, overaction of the contralateral synergist of the injected muscle made this difficult to maintain, and the two images slipped past one another. As the paralysis recovered, the area of binocular single vision gradually increased. In case 2, after five years with suppression of the deviating image and no stereopsis demonstrable, stereo acuity of 40 seconds of arc and a near normal fusion range were achieved, and in general the quality of stereopsis and fusion regained was better than had been expected before treatment. The period of overcorrection when the deviating image is moved well away from the suppression scotoma may explain this finding.
Experience with BTXA treatment of strabismus in patients without binocular functions"2 suggests that the eye tends to drift back to the original position as the paralytic effect of the injection declines. If stereopsis and fusion had not been re-established in these cases therefore, the pretreatment status would have been restored, whereas surgery may have led to intractable diplopia.
BTXA has also been advocated in the management of acute microvascular lateral rectus palsy, when injection of the ipsilateral medial rectus, by allowing the eye to abduct passively, enables a small central area of binocular co-operation to be achieved. It is expected that the two paralysed horizontal muscles would regain function at the same rate, gradually enlarging the area of the binocular single vision. We consider that these benefits to a group of patients with a good prognosis for recovering lateral rectus function are outweighed by disadvantages. A change in neurological signs may be obscured, and the reversal of diplopia on either side of the central binocular area is likely to be very uncomfortable. We are, however, extending the use of BTXA to the treatment of the medial rectus prior to surgery in cases of persistent abduction weakness requiring vertical muscle transposition, with encouraging results.
Conclusion
BTXA treatment of partly recovered adult paralytic strabismus is a simple, safe, cheap, and effective method which avoids the risks of a general anaesthetic. A larger area of binocular single vision may be achieved than by conventional surgery.
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